A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis


ÖZKAYA D., USTA SOFU G., KARACA U.

IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, vol.20, no.4, pp.505-508, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.18502/ijaai.v20i4.6961
  • Journal Name: IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
  • Page Numbers: pp.505-508
  • Keywords: Cyclosporine, Vernal keratoconjunctivitis, TOPICAL CYCLOSPORINE, 0.05-PERCENT, MANAGEMENT, PLAQUES
  • Süleyman Demirel University Affiliated: Yes

Abstract

Corneal shield ulcer is an uncommon but serious complication of vernal keratoconjunctivitis (VKC) that can threaten visual acuity. We present a 12-year-old case with a corneal shield ulcer on the superior part of the cornea in the right eye. We learned from his history that he was treated with topical cyclosporine A (CsA) and corneal debridement was performed for the same complaints six months ago. His complaints recurred six months after ceasing topical CsA voluntarily. Topical anti-allergic and CsA treatments were commenced, we also performed corneal debridement. During his followups, the corneal ulcer healed leaving a scar as opacity and neovascularization. This case highlights the role of the anti-inflammatory effect of CsA in preventing the recurrence of shield ulcers.